For Physicians For Patients
Text Size: A A A
Facebook LinkedIn Twitter

Find a Provider

American Health Network


For more information, please call us at 317-718-5482 or 877-340-7291.



The purpose of the Carmelina Study is to look at the impact of an investigational drug called linagliptin on the long-term occurrence of selected complications of cardiovascular disease (e.g. stroke or heart attack) in people with type 2 diabetes receiving standard of care

You may be eligible to take part in the Carmelina Study if:

  • You are 18 years of age or older
  • You have been diagnosed with type 2 diabetes
  • You have been receiving a stable dose of antidiabetic medication for at least 8 weeks or you have not previously received antidiabetic treatment
  • You have previously had problems with your heart (cardiovascular disease) and/or kidneys (renal disease)


You may be eligible to participate in this study if you:

  • Are 40 years of age or older. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
  • Have been diagnosed with type 2 diabetes
  • Have established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease.

Achieve Control Study

Has your doctor recommended that you begin taking insulin to control your diabetes?

If so, you may want to consider participating in Achieve Control……

Achieve Control is a real-world study sponsored by Sanofi and will include patients who are starting insulin for the first time. The study will evaluate how well patient reach their HbA1C targets using one of the marketed basal insulin without experiencing symptoms of low blood sugar such as dizziness etc.

You may be eligible if ……

  • You have Type 2 diabetes
  • You have used 2 or more anti-diabetes medications for at least 1 year
  • You have never used insulin ( except for temporary use during hospitalization or pregnancy)

Your participation in this study is voluntary and will last up to 12 months if you complete the study. The cost for the insulin and supplies will be provided by the study sponsor.


Are you tired of daily injections to control your type 2 diabetes?

This is a clinical research study looking at a potential new treatment approach for people with type 2 diabetes. The approach uses a small investigational device to release exenatide, the active ingredient in another approved medication, to help control your blood sugar levels over a period of up to 6 months, without the need for daily liraglutide (also known as Victoza®) injections.

Can you take part in the FREEDOM-3S Study?

You may be eligible to take part if you:

  • Are 18-80 years of age
  • Have been diagnosed with type 2 diabetes for at least 3 months
  • Have been taking liraglutide and metformin every day for at least 3 months

DS8500-A-U202 Diabetic Trial

The DS8500-A-U202 Study is a clinical research study looking at safety and effectiveness of a potential new treatment option for people with type 2 diabetes who are receiving metformin.

You may be able to take part in the study if you:

  • Are aged between 18 and 70 years, inclusive
  • Have been diagnosed with T2DM
  • Have been taking metformin (at least 1000mg/day) for at least 8 weeks

If you are eligible and choose to take part, you will be in the study for up to 18 weeks and will have about 8 visits at the study center. There will be no cost to you to participate.



If you currently have an abnormal lipid profile, you may qualify to participate in a clinical research study. To qualify, you must be at least 18 years of age, have triglyceride levels between 200 and 500 mg/dL, and meet other eligibility criteria. Study-related exams and medication/placebo may be provided to qualified participants.


Do you have high cholesterol and a history of Heart Disease, Kidney Disease, or Diabetes? If so you may qualify for a clinical research study.

You may qualify for this study if you:

  • Are at least 18 years old
  • Have high cholesterol
  • Are taking medication to treat high cholesterol
  • Have a history of heart disease, kidney disease, or diabetes



Do you have COPD (Chronic Obstructive Pulmonary Disease – also known as Chronic Bronchitis or Emphysema)? If so, a research study is currently underway to investigate the effectiveness of an investigational product in the reduction of the annual rate of COPD exacerbations.

Qualified Participants must:

  • Be at least 40 years of age
  • Have had a 10 pack years history of cigarette smoking
  • Be on a maintenance COPD treatment for at least 3 months
  • Have had a COPD exacerbation (or worsening) that required antibiotics, corticosteroids, or hospitalization within the past 12 months

COPD Trial

If you are living with moderate-to-severe COPD, you may qualify for a new clinical research study. The study is for an investigational medication that may help improve COPD symptoms.

You may be able to take part in the study if you:

  • At least 40 years old
  • Current or former smoker
  • Have been diagnosed with COPD, emphysema, or chronic bronchitis
  • Use oxygen no more than 15 hours per day
  • Able to attend required study visits


Birth Control Ring

Clinical Research doctors are studying an investigational vaginal ring for birth control. Doctors are conducting this study to evaluate whether the investigational vaginal ring is safe and effective.

Do I qualify?

The study staff will determine if you are eligible to participate. At a minimum, you must meet the following criteria:

  • Are a woman 18 years of age or older
  • Are heterosexually active and at risk for pregnancy
  • Must agree to avoid other forms of birth control while participating in the study


Milestone Stroke

The Milestone study is looking at the safety and effectiveness of a potential new medication for the treatment of walking problems in people who have had a stroke.

You may be able to take part if you:

  • Are 18 years of age or older
  • Have had an ischemic stroke
  • Have walking problems as a result of the ischemic stroke

The study will last about 5 months and will involve approximately 10 visits to a study center.

All study-related visits, assessments, and study medication will be provided at no cost to you. In addition, compensation for time and travel may be provided.

© Copyright 2017 AHN Target Holdings, LLC. All Rights Reserved.